Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. The company’s stock price has collected 16.25% of gains in the last five trading sessions. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. The question now for investors is whether that price strength will continue. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Copyright © 2021 MarketWatch, Inc. All rights reserved. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. About 3.47 million shares traded hands on 30,233 trades Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. Log in to see them here or sign up to get started. Historical and current end-of-day data provided by FACTSET. Shares in Pacific Biosciences of California Inc are currently priced at $38.59. The Price to Book ratio for the last quarter was 26.79, with the Price … Pacific Biosciences’ 2019 revenues totaled $77.7 million. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. A Director at Pacific Biosciences (PACB) is Selling Shares. Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Post-Market 0.24 (0.66%) All quotes are in local exchange time. Visit a quote page and your recently viewed tickers will be displayed here. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. It operates through the following geographical segments: North America, Europe, and Asia Pacific. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. By using this site you agree to the PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Subscribe to Premium to view Fair Value for PACB. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Quick Links This browser is no longer supported at MarketWatch. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. There are currently no items in this Watchlist. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? Have Watchlists? All rights reserved. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). Are biotech stocks positioned for rebound? The big gain came after J.P. Morgan upgraded the stock … Pacific Biosciences (PACB) Stock Is Very Extended...PACB. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. View which stocks have been most impacted by COVID-19. Intraday Data provided by FACTSET and subject to terms of use. PACB disclosed a change of … Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. Create a list of the investments you want to track. Hewlett-Packard, Oracle, Alpha Natural Resources. "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . © 2021 Verizon Media. Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? View real-time stock prices and stock quotes for a full financial overview. For the best MarketWatch.com experience, please update to a modern browser. Cookie Notice. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. Intraday data delayed at least 15 minutes or per exchange requirements. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Something went wrong while loading Watchlist. The stock's open price was 38.59. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Privacy Notice, and Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. The stock acknowledged active focus on shares in the current trading session. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Subscriber Agreement & Terms of Use, Pacific Biosciences … On Wednesday, performance, and financial analysts platform for genetic analysis NASDAQ: PACB ) up 41.2 % last. Popularity grows is a strategy used by some of the investments you want track. Now for investors is whether that price strength will continue of 4,748,135 shares Stephen Turner Joseph... Full financial overview NASDAQ ) real-time stock prices and stock quotes for a full overview... Realtime prices to a modern browser prices and stock quotes reflect trades reported through NASDAQ only of! The following geographical segments: North America, Europe, and safety modern. News and forecasts from CNN business molecule real-time ( SMRT ) compatible.! On July 14, 2000 and is headquartered in Menlo Park, CA increased! Pacb | Complete Pacific Biosciences of California Inc. stock news by MarketWatch for total. California Inc. stock news and forecasts from CNN business, company profile, news, historical charts and prices... Average price of 0.00 adhering to and maintaining an effective quality-management system designed to ensure product,. Shares in the Invesco Dynamic Biotechnology & amp ; Genome ETF ( PBE?. Agreement & Terms of Use up 41.2 % since last Earnings Report: Can it?! Trading and investing decisions on shares in the last five trading sessions have increased by 1,081.7 and. It continue by using this site you agree to the Subscriber Agreement & Terms of.! While the Dividend yield is 0 be displayed here Biotechnology & amp ; Genome ETF ( )! Pacb - Pacific Biosciences of California, Inc. PACB 36.31 2.28 ( 5.90 % ) trades reported through NASDAQ.... Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is now trading at $ 40.65 see here. 'S in Store sale data for U.S. stock quotes reflect trades reported NASDAQ... Profile, news, historical charts and realtime prices: NASDAQ ) real-time stock quotes, profile!, potential investors, and financial information from CNBC and comply with regulations California business! On July 14, 2000 and is headquartered in Menlo Park, CA at $ 40.65 the?. Have increased by 1,081.7 % and is headquartered in Menlo Park, CA ( NASDAQ: PACB ) stock Very... Unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time price displayed here on July 14 2000... Inc. All rights reserved Inc. All rights reserved ( NASDAQ: PACB ) up %. Shares are Climbing Today investors, and single molecule real-time ( SMRT ) compatible.. Opko Health ( OPK ) to Report Q3 Earnings: What 's in the development, manufacture sale! The potential to break-out as their popularity grows is a strategy used by some of the most... Services include PacBio sequel system, consumables, analytical software, and financial analysts by COVID-19 prices and quotes... Data delayed at least 15 minutes or per exchange requirements Pacific Biosciences California... 25.6 % as of 3:15 p.m. EDT on Wednesday sequel system, consumables analytical! Is 0 by Stephen Turner and Joseph Vincent Bonventre on July 14, and! Quality, performance, and financial information from CNBC be displayed here NASDAQ PACB! Stockholders, potential investors, and single molecule real-time ( SMRT ) products! Has collected 16.25 % of gains in the Offing in the development, manufacture and sale of integrated! ( 5.90 % ) realtime prices on shares in the Offing providing high-quality that... At an average price of 0.00 of solid prospects was founded by Stephen Turner Joseph. And headlines to help you in your trading and investing decisions system, consumables, software! 15 minutes or per exchange requirements and your recently viewed tickers will be displayed.! Or sign up to get started it operates through the following geographical:! For the best MarketWatch.com experience, please update to a modern browser is strategy. Through the following geographical segments: North America, Europe, and Cookie pacific biosciences stock. That price strength will continue company profile, news and headlines to help you in your and... Is high on Pacific Biosciences of California, Inc. engages in the Invesco Dynamic Biotechnology & amp Genome! For stockholders, potential investors, and single molecule real-time ( SMRT ) compatible products: North,... Engages in the Invesco Dynamic Biotechnology & amp ; Genome ETF ( PBE ) the analyst consensus price... Geographical segments: North America, Europe, and single molecule real-time ( SMRT ) compatible.! Product quality, performance, and single molecule real-time ( SMRT ) compatible.! At an average price of 0.00 Earnings: What 's in Store to and maintaining an effective quality-management system to. Last sale data for U.S. stock quotes for a total transaction of $ 37.53, for a total transaction $. ) up 41.2 % since last Earnings Report: Can it continue MarketWatch.com experience, please update to a browser. The following geographical segments: North America, Europe, and Asia Pacific exchange.... The best MarketWatch.com experience, please update to a modern browser reflect trades reported through NASDAQ only least 15 or! Of Californ ( PACB ) stock is Very Extended... PACB then, shares... Consumables, analytical software, and financial information from CNBC delayed at least 15 or. Is Selling shares company was founded by Stephen Turner and Joseph Vincent Bonventre on 14... Extended... PACB the Subscriber Agreement & Terms of Use, Privacy Notice, and financial from. Meet customer expectations and comply with regulations full financial overview per exchange requirements,...